Astrazeneca (NYSE:AZN)
AstraZeneca, born from the merger between Astra AB and Zeneca PLC, is a pharmaceutical giant that offers an attractive long-term yield with a prudent dividend policy. The company, which has thousands of employees worldwide, presents an interesting profile for investors despite some volatility, with a consistent Price/Earnings ratio and promising growth prospects.
Astrazeneca (NYSE:AZN) Read More »